Oxford Immunotec to Present at the 37th Annual J.P. Morgan Healthcare Conference
02 janv. 2019 09h00 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China
07 déc. 2018 09h00 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory...
Oxford Immunotec to Participate in Two Investor Conferences This Week
26 nov. 2018 17h31 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...
Oxford Immunotec Reports Third Quarter 2018 Financial Results
09 nov. 2018 07h15 HE
|
Oxford Immunotec Global PLC
Closed transformative deal to sell U.S. laboratory services business to Quest DiagnosticsT-SPOT®.TB tests sold in the third quarter exceeded one million tests for the first timeSignificant improvement...
Oxford Immunotec Schedules Third Quarter 2018 Earnings Release and Business Update Conference Call for November 9, 2018
06 nov. 2018 17h12 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it plans...
Oxford Immunotec Reports Second Quarter 2018 Financial Results
31 juil. 2018 07h00 HE
|
Oxford Immunotec Global PLC
Second quarter Tuberculosis (TB) revenue growth of 17%, with record TB revenue in the United StatesGross margin improved by 450 basis points compared to prior year period and 630 basis points on a...
Oxford Immunotec Launches T-Cell Select™ to Enable Full Automation of the T-SPOT®.TB Test, Provides Unrivaled Sample Stability and Simplicity of Blood Collection
31 juil. 2018 06h55 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced the launch of...
Oxford Immunotec Schedules Second Quarter 2018 Earnings Release and Conference Call for July 31, 2018
17 juil. 2018 08h30 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it plans...
Oxford Immunotec Applauds Updated Guidelines from the American Academy of Pediatrics Supporting Expanded Use of the T-SPOT®.TB Test
05 juin 2018 08h30 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that it...
Oxford Immunotec Announces Data Presentations for T-SPOT®.CMV Test at the 2018 American Transplant Congress
04 juin 2018 08h30 HE
|
Oxford Immunotec Global PLC
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that data from...